$INSM News

A Look At Insmed (INSM) Valuation After Recent Share Price Weakness And Brensocatib Launch Expectations

ATS 2026: Insmed shines in bronchiectasis with spotlight on Brinsupri

Insmed Incorporated (INSM) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript

Assessing Insmed (INSM) Valuation After Recent Share Price Pullback And Strong Multi Year Returns

Insmed CEO Defends BRINSUPRI Launch as Sales Surge, TPIP Pipeline Gains Focus

Insmed Files For Mixed Shelf Offering; Size Not Disclosed

Truist Securities Maintains Buy on Insmed, Lowers Price Target to $185

Insmed Incorporated (INSM) Reports Q1 2026 Results

Insmed (INSM) Soars on Bargain-Hunting After 10-Month Low

Insmed Incorporated (INSM) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Here's What Analysts Are Forecasting For Insmed Incorporated (NASDAQ:INSM) After Its First-Quarter Results

Insmed Stock Sell-off is Overdone as Underlying Metrics Appear Positive, RBC Says

Insmed's Q1 Earnings Beat, Sales Miss Estimates, Stock Tanks 23%

RBC Capital Maintains Outperform on Insmed, Lowers Price Target to $205

Wells Fargo Maintains Overweight on Insmed, Lowers Price Target to $160

Guggenheim Maintains Buy on Insmed, Lowers Price Target to $226

Insmed Q1 Earnings Call Highlights

Insmed Incorporated Q1 2026 Earnings Call Summary

Insmed Tanks On Its Most Important Launch; Why Analysts Remain Bullish

Insmed Incorporated (INSM) Q1 2026 Earnings Call Transcript